ascendis pharma glp-1 receptor agonist weight management diabetes treatments Novo inks deal to develop long-acting GLP-1, other metabolic drugs Frontiers | GLP−1 receptor agonists
Description
Interestingly, many patients taking drugs such as Ozempic and Zepbound have reported similar experiences, saying their cravings for alcohol, cigarettes, or other substances decreased after starting treatment
Daily oral GLP-1 pill delivers strong results treating diabetes and obesity A new daily pill called orforglipron helped adults lose weight and improve blood sugar levels in long global trials
Nonetheless, exposure to high doses of DB (5 mM) has been associated with cellular apoptosis in pancreatic islets
The GLP-1RA liraglutide has also been approved for the treatment of obesity at a higher standard dose (3 mg once daily) compared to the standard dose used for T2D treatment (1.2 mg once daily) due to the results of the SCALE study program (37, 38)
Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors
Molecular Insights into the Potential Cardiometabolic Effects of GLP-1 Receptor Analogs and DPP-4 Inhibitors
